13.93BMarket Cap-82130P/E (TTM)
19.020High18.500Low278.81KVolume18.720Open18.980Pre Close5.24MTurnover0.27%Turnover RatioLossP/E (Static)737.45MShares33.89052wk High31.80P/B1.94BFloat Cap1.89052wk Low--Dividend TTM102.77MShs Float33.890Historical High--Div YieldTTM2.74%Amplitude0.660Historical Low18.802Avg Price1Lot Size
Summit Therapeutics Stock Forum
$Nxu Inc (NXU.US)$ grab some on your way out.
After the dual-antibody drug data from Summit Therapeutics (SMMT.US) defeated the "drug king", it was listed as Citigroup's preferred stock and the target price was raised.
No comment yet